Background {#Sec1}
==========

Despite the decreasing overall worldwide incidence of gastric cancer in the recent decades, it is still the fifth most common malignant tumors and the third leading cause of cancer-associated death in the world \[[@CR1]\]. Furthermore, it is the second commonest cancer in China \[[@CR2]\]. Surgical resection with extended lymph node clearance remains the only curative option for non-metastatic gastric cancer \[[@CR3]--[@CR5]\]. Although with the significant improvement in surgical techniques and adjuvant therapy, the prognosis of gastric cancer is still not promising \[[@CR6]\]. Thus, the prognostic risk factors for gastric cancer have been widely investigated, and age, tumor location, tumor size, tumor depth and lymph node metastasis, etc. \[[@CR4], [@CR7], [@CR8]\] have already been demonstrated to be associated with the prognosis of gastric cancer patients previously.

Up to date, the investigation of the prognostic value of differentiation status mainly focused on signet ring cell (SRC) and mucinous carcinoma, which were classified as undifferentiated type according to the Japanese classification of gastric carcinoma \[[@CR9]\]. However, the prognostic significance of SRC and mucinous gastric carcinoma are still controversial \[[@CR10]--[@CR14]\]. Previously, we also investigated the clinicopathological features and prognostic value of mucinous gastric cancer, and found that the prognosis of mucinous tumor was comparable with non-mucinous tumor \[[@CR15]\]. However, the clinicopathological characteristics and prognosis of patients with well, moderately and poorly differentiated gastric cancer have not been reported yet. Thus, the present study aims to investigate the clinicopathological features and prognosis of gastric cancer patients with well, moderately and poorly differentiation status.

Methods {#Sec2}
=======

This study was performed in the Division of Digestive Surgery, Xijing Hospital of Digestive Diseases. From September 2008 to March 2015, a total of 3090 consecutive gastric cancer patients were enrolled in the present study. All patients were treated with radical D2 gastrectomy \[[@CR16]\] and regular follow up. This study was approved by the Ethics Committee of Xijing Hospital, and written informed consent was obtained from all patients before surgery.

Clinicopathological data including age, gender, tumor location, tumor size, differentiation status, tumor depth, lymph node metastasis and tumor stage were collected. Patients were divided into three groups according to differentiation status: well, moderately and poorly differentiation. The patients were followed up till November 2016.

Data were processed using SPSS 22.0 for Windows (SPSS Inc., Chicago, IL, USA). Discrete variables were analyzed using Chi-square test or Fisher's exact test. We respectively matched the 1884 patients in poorly differentiation group and 836 patients in moderately differentiation group to the 370 patients who in well differentiation group with a 1:1 matched ratio. The gmatch macro of SAS 9.2 (SAS institute, Cary, NC, USA) written by Erik Bergstralh & Jon Kosanke (<http://bioinformaticstools.mayo.edu/research/gmatch/>) was used to execute this pair matching process. The principle of this macro is computerized matching of cases to controls using the greedy matching algorithm with a fixed number of controls per case. Controls may be matched to cases using one or more factors (X's). In this study, we set patients in well differentiation group as cases, and patients in moderately or poorly group as controls. The matching condition/factors we set among the four groups based on the following three parameters: age (±10 years), tumor size (±1 cm), T stage and N stage. The study endpoint was OS (Overall survival), the time to event was computed from the date of surgery to the date when the death (any cause) was recorded. Overall survival curves were estimated by the Kaplan-Meier method and comparison between survival curves was performed using the log-rank test. The *p* value was considered to be statistically significant at 5% level.

Results {#Sec3}
=======

There were 2422 male (78.4%) and 668 female (21.6%). The median age was 58 (20--90) years. There were 370 (12.0%) well differentiated tumors, 836 (27.0%) moderately differentiated tumors and 1884 (61.0%) poorly differentiated tumors. The associations between differentiation status and clinicopathological features were summarized in Table [1](#Tab1){ref-type="table"}. The proportion of well and moderately differentiation status were higher in patients older than 60 years old, in male patients and in patients with tumors smaller than 5 cm. It also gradually decreased along with the T stage, N stage and TNM stage. Inversely, the proportion of poorly differentiation status was higher in patients younger than 60 years old, in female patients and in patients with tumors larger than 5 cm. It also gradually increased along with T stage, N stage and TNM stage.Table 1Clinicopathological characteristics of gastric cancer patientsCharacteristicsWell, *n* (%)Moderately, *n* (%)Poorly, *n* (%)*P* valueAge\< 0.001  ≤ 60197(10.8)406(22.2)1226(67.0) \>60173(13.7)430(34.1)658(52.2)Gender\< 0.001 Male308(12.7)716(29.6)1398(57.7) Female62(9.3)120(18.0)486(72.7)Tumor location\< 0.001 Upper third146(14.9)351(35.7)485(49.4) Middle third47(9.3)108(21.4)350(69.3) Lower third163(12.0)329(24.2)867(63.8) Cross or entire14(5.7)48(19.7)182(74.6)Tumor size\< 0.001  ≤ 5332(15.3)613(28.2)1228(56.5) \>538(4.2)223(24.3)656(71.5)Tumor depth\< 0.001 T1193(32.9)165(28.2)228(38.9) T249(10.1)153(31.5)284(58.4) T396(8.6)351(31.4)670(60.0) T432(3.6)167(18.5)702(77.9)Lymph node metastasis\< 0.001 N0274(24.2)360(31.8)498(44.0) N152(8.8)200(33.8)340(57.4) N227(5.1)142(26.8)361(68.1) N317(2.0)134(16.0)685(82.0)Tumor stage\< 0.001 I225(28.9)241(31.0)312(40.1) II93(10.1)316(34.3)511(55.6) III52(3.7)279(20.1)1061(76.2)

The overall survival of patients with different differentiation status were analyzed and shown in Fig. [1](#Fig1){ref-type="fig"}. The results showed that the overall survival of patients was gradually decreased along with the differentiation status. However, the difference only existed in patients with stage III tumors in the subgroup analysis.Fig. 1Overall survival of patients with different differentiation status

Due to the unbalanced baseline distribution, patients in the three groups were matched based on age, tumor size, T stage and N stage. The clinicopathological features were compared and shown in Table [2](#Tab2){ref-type="table"}. The results showed that the distribution of age, tumor size, T stage, N stage and TNM stage were all comparable among the three groups (all *p* \> 0.05). Further, the overall survival of patients was analyzed and shown in Fig. [2](#Fig2){ref-type="fig"}. The results showed that there was no significant difference among the prognosis of three groups.Table 2Clinicopathological characteristics of gastric cancer patients after matchCharacteristicsWellModeratelyPoorly*P* valueAge0.761  ≤ 60176180185 \>60131127122Gender0.001 Male254264230 Female534377Tumor location\< 0.001 Upper third12311160 Middle third364560 Lower third135141170 Cross or entire131017Tumor size0.654  ≤ 5271270264 \>5363743Tumor depth1.000 T1132132132 T2484848 T3969696 T4313131Lymph node metastasis1.000 N0213213213 N1505050 N2272727 N3171717Tumor stage0.999 I164164164 II929494 III514949Fig. 2Overall survival of patients with different differentiation status after match

Discussion {#Sec4}
==========

Up to date, the investigation of the prognostic value of differentiation status mainly focused on SRC and mucinous gastric carcinoma. Although SRC and mucinous carcinoma have long been regarded as adverse prognostic risk factors of gastric cancer, the findings of previous reports were inconsistent. This may attribute to the different sample size, race and inclusion criteria etc. in these studies. Further, in the previous reports, gastric cancer patients with SRC or mucinous differentiation status were always compared with non-SRC or non-mucinous differentiation status. The features of patients with well, moderately and poorly differentiation status have not been investigated in detail. Thus, our present study aims to elucidate the clinicopathological characteristics and prognosis of gastric cancer patients with well, moderately and poorly differentiation status. We found that differentiation status was significantly associated with age, gender, tumor location, tumor size, tumor depth, lymph node metastasis and tumor stage, but not the prognosis of gastric cancer.

In many previous reports, SRC histology appears to occur frequently in female and young patients \[[@CR13], [@CR17]--[@CR19]\], whereas mucinous histology was not associated with gender and age of patients \[[@CR10], [@CR15], [@CR20]\]. In our present study, the distribution of differentiation status was significantly associated with gender and age of patients. In detail, well and moderately differentiation status occurred more frequently in male and old patients, whereas poorly differentiation status mainly occurred in female and young patients. This was similar to the findings in patients with SRC histology in the previous reports.

Both SRC and mucinous histology were reported to be significantly associated with larger tumor size, deeper tumor invasion, more lymph node metastasis and later tumor stage in the previous reports \[[@CR10], [@CR13], [@CR15], [@CR20]\]. In our present study, we found the same tendency. Moreover, we found that the proportion of well and moderately differentiation status gradually decreased along with the T, N and TNM stage. Inversely, the proportion of poorly differentiation status gradually increased along with T, N and TNM stage. This indicated that well-moderately-poorly differentiation status transition or dedifferentiation-redifferentiation may occur in single tumor during progression of disease \[[@CR21]--[@CR26]\]. However, the potential mechanism needs further investigation.

Up to date, reports about the prognostic value of differentiation status mainly focused on SRC and mucinous carcinoma, and results were inconsistent. Piessen et al. reported that SRC histology was an independent risk factor for the poor prognosis of gastric cancer \[[@CR14]\]. Postlewait et al. reported that SRC histology was not independently associated with reduced recurrence free survival and overall survival \[[@CR13]\]. However, Wang et al. reported that SRC histology had a relatively favorable prognosis of early gastric cancer \[[@CR12]\]. In addition, findings about the prognostic value of mucinous carcinoma were also controversial \[[@CR10], [@CR11], [@CR20], [@CR27]\]. The association between well, moderately and poorly differentiation status and prognosis of gastric cancer patients have never been investigated before. In our present study, differentiation status was significantly associated with the overall survival of gastric cancer patients through Kaplan-Meier analysis. However, considering the significant association between pathological features and differentiation status, patients in the three groups were matched based on age, tumor size, T stage and N stage. As a result, the overall survival was comparable between well, moderately and poorly differentiation status after match. This indicated that well, moderately and poorly differentiation status was not associated with the prognosis of gastric cancer patients.

There were several limitations in our present study. First, it was a retrospective and single center analysis with relatively limited sample size. Multi-center studies are needed to verify the findings in our present study. Second, disease free survival and disease specific survival were not analyzed. Third, only age, tumor size, T stage and N stage were matched, which may result in bias during analysis. Fourth, SRC and mucinous histology were not included in the present analysis.

Conclusions {#Sec5}
===========

Well, moderately and poorly differentiation status was significantly associated with clinicopathological features of gastric cancer patients. However, it was not associated with the prognosis of gastric cancer patients.

SRC

:   signet ring cell
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